Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: J Cancer Surviv. 2014 Feb 28;8(2):156–166. doi: 10.1007/s11764-014-0349-3

Appendix Table 6.

Multivariable regression analyses* showing the association between care density and outcomes; models do not and do include the number of doctors visits as a covariate. Care density is constructed using all primary care, oncology specialists, and other providers during Days 366 to 1095.

Base model Including total number of doctors as covariate

beta-coefficient (95% CI) beta-coefficient (95% CI)

Total costs
<2 providers 2888 (1499 – 4277) 1938 (498 – 3379)
Low care density 0 0
Middle care density 1742 (2742 –741) 1292 (2308 –277)
High care density 2116 (3107 –1125) 2006 (2997 –1015)
Inpatient costs^
<2 providers 1236 (101 – 2371) 773 (−300 – 1847)
Low care density 0 0
Middle care density −419 (−936 – 99) −277 (−813 – 258)
High care density 666 (1138 –1957) 609 (1079 –139)
Outpatient costs
<2 providers 339 (579 –99) 139 (−108 – 385)
Low care density 0 0
Middle care density 119 (−54 – 291) −108 (−281 – 66)
High care density 465 (636 –294) 520 (690 –351)
*

Analyses are adjusted for age, gender (except breast/prostate models), race, SEER site, cancer type, state buy-in, urban/rural residence, total number of visits, visit with PCP, and Charlson comorbidity index

^

Two part models with recycled predictions and bootstrapping to estimate confidence intervals

bold = significant at p<0.05